Procter & Gamble is buying supplement brand Thorne for $3.8 billion, CEO Shailesh Jejurikar said on CNBC’s “Squawk on the Street.”
The acquisition, which is set to be announced Tuesday, is a bid for P&G to grow its health and wellness division. The consumer goods giant already owns several other supplements brands, like Metamucil, Align Probiotic and New Chapter vitamins, which are housed within a broader healthcare division that includes Oral-B and Vick’s.
“We are really happy with the asset itself,” Jejurikar told CNBC’s Sara Eisen. “It’s a really well-run operation, and it’s been around for a long time.”
Thorne was founded in 1984 and went public in late 2021 at a valuation of $525 million. L Catterton then took the company private in 2023 in a deal valued at $680 million. Its annual revenue surpassed $500 million in 2025, according to Thorne.
Thorne’s Magnesium Glycinate and Ginseng Plus supplements.
Courtesy: Thorne
Thorne CEO Colin…
